+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neurotransmitter"

XYWAV, Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

XYWAV, Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
XYREM (Sodium oxybate) Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

XYREM (Sodium oxybate) Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
WAKIX (Pitolisant), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

WAKIX (Pitolisant), Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Epilepsy- Competitive Landscape, Market and Pipeline Analysis, 2020 - Product Thumbnail Image

Epilepsy- Competitive Landscape, Market and Pipeline Analysis, 2020

  • Drug Pipelines
  • March 2020
  • 100 Pages
  • Global
From
Stuttering - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Stuttering - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • March 2022
  • 96 Pages
  • Global
From
Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
LAMEA Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

LAMEA Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Country and Growth Forecast, 2022 - 2028

  • Report
  • August 2022
  • 70 Pages
  • Middle East, Africa
From
Neuropeptide Y Receptor Type 2 - Pipeline Review, H2 2020 - Product Thumbnail Image

Neuropeptide Y Receptor Type 2 - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 39 Pages
  • Global
From
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H2 2020 - Product Thumbnail Image

5-Hydroxytryptamine Receptor 6 - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 62 Pages
  • Global
From
Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 - Pipeline Review, H2 2020 - Product Thumbnail Image

Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 33 Pages
  • Global
From
Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 41 Pages
  • Global
From
Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 35 Pages
  • Global
From
Alzheimer's Disease (Central Nervous System) - Drugs In Development, 2021 - Product Thumbnail Image

Alzheimer's Disease (Central Nervous System) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 2055 Pages
  • Global
From
Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Pipeline Review, H2 2018 - Product Thumbnail Image

Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Pipeline Review, H2 2018

  • Drug Pipelines
  • August 2018
  • 50 Pages
  • Global
From
Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 12 - Product Thumbnail Image

Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 12

  • Book
  • March 2024
Neuroprotection - Methods, Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Methods, Drugs, Markets and Companies

  • Report
  • November 2021
  • 844 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Treatment Market By Drugs, By Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Treatment Market By Drugs, By Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • April 2023
  • 260 Pages
  • Global
From
Botulinum Toxin Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Thumbnail Image

Botulinum Toxin Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • October 2022
  • 215 Pages
  • Global
From
Tardive Dyskinesia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Tardive Dyskinesia Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Global Narcolepsy Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Narcolepsy Drugs Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
Loading Indicator

The Neurotransmitter market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neurotransmitters are chemicals that are released by neurons to send signals to other cells. These drugs are used to treat a variety of neurological disorders, including depression, anxiety, and schizophrenia. Neurotransmitter drugs work by either increasing or decreasing the amount of neurotransmitters in the brain. The Neurotransmitter market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and Merck. Other companies such as Novartis, AstraZeneca, and Johnson & Johnson also have a presence in the Neurotransmitter market. Show Less Read more